Bio-UV Group: 2024 Results and 2025 Outlook

Bio-UV Group announced its 2024 annual results, posting an EBITDA margin of 13.5%, marking five consecutive years of double-digit profitability. Although revenue declined 8% to €39.6 million, free cash flow reached a record level of €5.0 million. This flow enabled a reduction in net financial debt of €4.7 million.

For 2025, the company is aiming for a return to organic growth, driven by export sales from its Solutions and Services divisions. The goal is also to improve profitability and continue debt reduction. The new sales organization, effective since January 2025, should facilitate these ambitions.

Thanks to a fundraising of €7.7 million in early 2025, the group plans to develop new services and conquer new markets, particularly in North America.